Search - tctmd.com

Displaying 81 - 100 of 648

Sort: Relevancy | Date

Presentation TVT 2021

My Top Picks: Innovation that will Shape the Future of Trans-Catheter Aortic Valve Therapies

Presenter: Martin Leon

July 21, 2021

Presentation TVT 2021

Intrepid TMVR Trial Overview and Update

Presenter: Martin Leon

July 21, 2021

Presentation TVT 2021

Trans-Apical Systems: Clinical Experiences in Large RCTs and Registries

Presenter: Martin Leon

July 21, 2021

Presentation TVT 2021

Randomized Trials Are Nice to Have but Not Always Practical!

Presenter: Martin B. Leon

July 20, 2021

Presentation TVT 2021

How ACURATE neo2 Improves Outcomes

Presenter: Won-Keun Kim

July 20, 2021

Presentation TVT 2021

Improving Future Coronary Access: A Step by Step Guidance to Achieve Commissural Alignment

Presenter: Mohamed Abdel-Wahab

July 20, 2021

Presentation TVT 2021

To Debris or Not To Debris - CEP. That is the Question

Presenter: Amar Krishnaswamy

July 20, 2021

News Conference News EuroPCR 2021

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Michael O'Riordan

May 19, 2021

Presentation Fellows 2021

Lessons Learned from a Career in Interventional Discovery

Presenter: Martin B. Leon

May 08, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2021

Shelley Wood

April 02, 2021

News Daily News

Published 2-Year Partner 3 Data Shed New Light on TAVI, SAVR Choice in Low-risk Patients

Yael L. Maxwell

March 02, 2021

News Daily News

Anthony Gershlick, Esteemed UK Cardiologist, Dies at 69

L.A. McKeown

November 20, 2020

News Industry News

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

November 17, 2020

Presentation TCT 2020

TAVR in Low Surgical Risk Patients - Evidence Updates From PARTNER 3

Presenter: Martin Leon

October 16, 2020

News Conference News TCT 2020

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Shelley Wood

October 15, 2020

News Conference News TCT 2020

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

Todd Neale

October 15, 2020

News Daily News

James T. Willerson, Revered Clinician, Editor, and Mentor, Dies at 81

L.A. McKeown

September 18, 2020

News Daily News

Kenneth Kent, Angioplasty Pioneer and Original TCT Co-Director, Dies at 81

Yael L. Maxwell

May 22, 2020

News Conference News ACC 2020

Edoxaban May Be Alternative to Warfarin After Surgical Valve Implantation or Repair

L.A. McKeown

April 07, 2020

Presentation JIM 2020

The TAVR Odyssey: From niche therapy to standard-of-care and beyond…

Presenter: Martin B. Leon

February 12, 2020

Advertisement

My Top Picks: Innovation that will Shape the Future of Trans-Catheter Aortic Valve Therapies

Intrepid TMVR Trial Overview and Update

Trans-Apical Systems: Clinical Experiences in Large RCTs and Registries

Randomized Trials Are Nice to Have but Not Always Practical!

How ACURATE neo2 Improves Outcomes

Improving Future Coronary Access: A Step by Step Guidance to Achieve Commissural Alignment

To Debris or Not To Debris - CEP. That is the Question

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Lessons Learned from a Career in Interventional Discovery

TCTMD’s Top 10 Most Popular Stories for March 2021

Published 2-Year Partner 3 Data Shed New Light on TAVI, SAVR Choice in Low-risk Patients

Anthony Gershlick, Esteemed UK Cardiologist, Dies at 69

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

TAVR in Low Surgical Risk Patients - Evidence Updates From PARTNER 3

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Efficacy Eludes TriGUARD 3 Cerebral Protection Device: REFLECT II

James T. Willerson, Revered Clinician, Editor, and Mentor, Dies at 81

Kenneth Kent, Angioplasty Pioneer and Original TCT Co-Director, Dies at 81

Edoxaban May Be Alternative to Warfarin After Surgical Valve Implantation or Repair

The TAVR Odyssey: From niche therapy to standard-of-care and beyond…

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content